Comparison between Entero Healthcare Solutions IPO and Exicom Tele-Systems IPO.
Entero Healthcare Solutions IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Exicom Tele-Systems IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Entero Healthcare Solutions IPO is up to ₹1,600.00 Cr whereas the issue size of the Exicom Tele-Systems IPO is up to ₹429.00 Cr. The final issue price of Entero Healthcare Solutions IPO is ₹1,258.00 per share and of Exicom Tele-Systems IPO is ₹142.00 per share.
| Entero Healthcare Solutions IPO | Exicom Tele-Systems IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹1,195.00 per share | ₹135.00 per share |
| Issue Price (Upper) | ₹1,258.00 per share | ₹142.00 per share |
| Issue Price (Final) | ₹1,258.00 per share | ₹142.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹119.00 per share | |
| Market Lot Size | 11 shares | 100 shares |
| Fresh Issue Size | 79,52,518 shares | 2,31,69,000 shares |
| Fresh Issue Size (Amount) | up to ₹1,000.31 Cr | up to ₹329.00 Cr |
| OFS Issue Size | 47,67,526 shares | 70,42,200 shares |
| OFS Issue Size (Amount) | up to ₹599.69 Cr | up to ₹100.00 Cr |
| Issue Size Total | 1,27,20,044 shares | 3,02,11,200 shares |
| Issue Size Total (Amount) | up to ₹1,600.00 Cr | up to ₹429.00 Cr |
Entero Healthcare Solutions IPO opens on Feb 09, 2024, while Exicom Tele-Systems IPO opens on Feb 27, 2024. The closing date of Entero Healthcare Solutions IPO and Exicom Tele-Systems IPO is Feb 13, 2024, and Feb 29, 2024, respectively.
| Entero Healthcare Solutions IPO | Exicom Tele-Systems IPO | |
|---|---|---|
| Anchor Bid Date | Feb 08, 2024 | Feb 26, 2024 |
| Issue Open | Feb 09, 2024 | Feb 27, 2024 |
| Issue Close | Feb 13, 2024 | Feb 29, 2024 |
| Basis Of Allotment (Tentative) | Feb 14, 2024 | Mar 01, 2024 |
| Initiation of Refunds (Tentative) | Feb 15, 2024 | Mar 04, 2024 |
| Credit of Share (Tentative) | Feb 15, 2024 | Mar 04, 2024 |
| Listing date (Tentative) | Feb 16, 2024 | Mar 05, 2024 |
| Anchor Lockin End date 1 | Mar 15, 2024 | Mar 31, 2024 |
| Anchor Lockin End date 2 | May 14, 2024 | May 30, 2024 |
Entero Healthcare Solutions IPO P/E ratio is 0, as compared to Exicom Tele-Systems IPO P/E ratio of 217.63.
| Entero Healthcare Solutions IPO | Exicom Tele-Systems IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 77.11 | 93.28 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 52.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 0 | 217.63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹3021.21 Cr. | ₹1715.71 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | -2.66% | 13.38% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 6.06% | 10.92% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹0.00 | ₹0.65 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -1.86% | 2.75% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Entero Healthcare Solutions IPO Retail Individual Investors (RII) are offered 12,65,500 shares while in Exicom Tele-Systems IPO retail investors are offered 12,65,500 shares. Qualified Institutional Buyers (QIB) are offered 37,96,503 shares in Entero Healthcare Solutions IPO and 1,01,19,700 shares in Exicom Tele-Systems IPO.
| Entero Healthcare Solutions IPO | Exicom Tele-Systems IPO | |
|---|---|---|
| Anchor Investor Reservation | 56,94,753 shares | 1,25,38,800 shares |
| Market Maker Reservation | ||
| QIB | 37,96,503 shares | 1,01,19,700 shares |
| NII | 18,98,251 shares | 45,31,600 shares |
| RII | 12,65,500 shares | 30,21,100 shares |
| Employee | 70,237 shares | |
| Others | ||
| Total | 1,27,25,244 shares | 3,02,11,200 shares |
Entero Healthcare Solutions IPO subscribed 1.53x in total, whereas Exicom Tele-Systems IPO subscribed 133.56x.
| Entero Healthcare Solutions IPO | Exicom Tele-Systems IPO | |
|---|---|---|
| QIB (times) | 2.28x | 124.82x |
| NII (times) | 0.22x | 159.29x |
| Big NII (times) | 0.16x | 163.96x |
| Small NII (times) | 0.33x | 149.95x |
| RII (times) | 1.33x | 124.27x |
| Employee (times) | 1.25x | |
| Other (times) | ||
| Total (times) | 1.53x | 133.56x |
